Completed NA INTERVENTIONAL 2-arm NCT01194557

Introducing Rapid Diagnostic Tests Into the Private Health Sector

Introducing Rapid Diagnostic Tests Into the Private Health Sector in Uganda: a Randomised Trial Among Registered Drug Shops to Evaluate Impact on Antimalarial Drug Use

Sponsor: Artemisinin-based Combination Therapy

Conditions Diagnosis Fever Malaria Referral

Interventions Lumartem Rapid diagnostic test

Updated 5 times since 2017 Last updated: Oct 11, 2012 Started: Sep 30, 2010 Primary completion: Jul 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01194557, this NA trial focuses on Diagnosis and Fever and remains completed. Sponsored by Artemisinin-based Combination Therapy, it has been updated 5 times since 2010, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Artemisinin-based Combination Therapy
DBL -Institute for Health Research and Development
London School of Hygiene and Tropical Medicine
Ministry of Health, Uganda

Data source: DBL -Institute for Health Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mukono, Uganda